Clinical Trial Update: Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tetracycline prophylaxis to prevent rash in non-small cell lung cancer patients treated with afatinib (BIBW2992); trial completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Afatinib (Gilotrif) (afatinib)
• tetracycline (tetracycline)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Skin Rash, Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-12